#Latest news with #gefurulimabReuters24-07-2025HealthReutersAstraZeneca's immune disorder drug succeeds in late-stage trialJuly 24 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Thursday its experimental therapy gefurulimab met the main goal of a late-stage study looking into improving symptoms of a chronic, autoimmune condition known as generalised myasthenia gravis in adults.
Reuters24-07-2025HealthReutersAstraZeneca's immune disorder drug succeeds in late-stage trialJuly 24 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Thursday its experimental therapy gefurulimab met the main goal of a late-stage study looking into improving symptoms of a chronic, autoimmune condition known as generalised myasthenia gravis in adults.
24-07-2025
